Vivo Capital’s Unicycive Therapeutics UNCY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.42M | Hold |
1,137,015
| – | – | 0.56% | 35 |
|
|
2025
Q1 | $6.54M | Buy |
1,137,015
+140,000
| +14% | +$805K | 0.87% | 27 |
|
|
2024
Q4 | $7.92M | Buy |
997,015
+550,000
| +123% | +$4.37M | 0.89% | 27 |
|
|
2024
Q3 | $1.82M | Buy |
447,015
+100,000
| +29% | +$408K | 0.15% | 37 |
|
|
2024
Q2 | $1.74M | Hold |
347,015
| – | – | 0.16% | 35 |
|
|
2024
Q1 | $4.79M | Hold |
347,015
| – | – | 0.38% | 36 |
|
|
2023
Q4 | $3.01M | Hold |
347,015
| – | – | 0.25% | 41 |
|
|
2023
Q3 | $2.98M | Buy |
+347,015
| New | +$2.98M | 0.33% | 41 |
|